XTX Topco’s Charles River Laboratories CRL Stock Holding History

XTX Topco’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$322K	Sell	1,419 -2,154	-60%	-$384K	﹤0.01%	2854
2026 Q1	$616K	Buy	+3,573	New	+$662K	0.01%	1832
2025 Q1	–	Sell	-2,921	Closed	-$539K	–	2517
2024 Q4	$539K	Buy	+2,921	New	+$563K	0.04%	711
2024 Q2	–	Sell	-1,217	Closed	-$330K	–	1967
2024 Q1	$330K	Buy	+1,217	New	+$291K	0.04%	770
2023 Q4	–	Sell	-5,426	Closed	-$1.06M	–	1679
2023 Q3	$1.06M	Buy	+5,426	New	+$1.11M	0.18%	83
2023 Q2	–	Sell	-1,161	Closed	-$234K	–	1478
2023 Q1	$234K	Sell	1,161 -460	-28%	-$104K	0.05%	838
2022 Q4	$353K	Buy	+1,621	New	+$354K	0.08%	482
2021 Q4	–	Sell	-1,444	Closed	-$596K	–	739
2021 Q3	$596K	Buy	+1,444	New	+$600K	0.2%	138
2021 Q2	–	Sell	-1,009	Closed	-$292K	–	850
2021 Q1	$292K	Buy	+1,009	New	+$280K	0.14%	285

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

XTX Topco's CRL Position: Q2 2026 in Review

XTX Topco reduced its Charles River Laboratories (CRL) stake by 60% in Q2 2026, selling an estimated $384K and leaving 1,419 shares worth $322K. The position accounts for ﹤0.01% of the portfolio, ranked #2854.

XTX Topco first reported a position in CRL in Q1 2021 and has held it in 9 quarters since. The position peaked at $1.06M in Q3 2023. 569 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

XTX Topco held 1,419 shares of Charles River Laboratories worth $322K as of Q2 2026.
XTX Topco sold 2,154 Charles River Laboratories shares in Q2 2026, an estimated $384K.
Charles River Laboratories made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #2854 holding.
XTX Topco first reported a position in Charles River Laboratories in Q1 2021 and has held it in 9 quarters since.
XTX Topco's Charles River Laboratories position peaked at $1.06M in Q3 2023.
569 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.